EP0093: An Open-Label, Multicenter, Extension Study to Evaluate the Safety and Efficacy of Padsevonil (the "Study Product") as Adjunctive Treatment of Foca-Onset Seizures in Adult Subjects with Drug-Resistent Epilepsy